by Josh Forsythe, on July 19, 2016
ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to clinical labs. Under the terms of the agreement, PierianDx will …
Read StoryCheck back regularly for engaging perspectives on clinical genomics.